Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Misoprostol and isosorbide mononitrate for therapeutic abortion
IRCT20250826067009N1Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of misoprostol and isosorbide mononitrate in abortion (3 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoint: Success of therapeutic abortion. Started Sep 2025; status: completed.
02
Drugs
misoprostolisosorbide mononitrate
03
Conditions
abortion
Beyond the preview
Go deeper on IRCT20250826067009N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20250826067009N1.